uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort
Skane Univ Hosp, Dept Urol, SE-20502 Malmo, Sweden.;Lund Univ, Div Urol Canc, Dept Translat Med, S-22100 Lund, Sweden..
Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden..
Sahlgrens Univ Hosp, Dept Cardiothorac Surg, Gothenburg, Sweden..
Lund Univ, Div Urol Canc, Dept Translat Med, S-22100 Lund, Sweden.;Cambridge Univ Hosp, Dept Urol, Cambridge, England..
Show others and affiliations
2016 (English)In: Scandinavian journal of urology, ISSN 2168-1805, E-ISSN 2168-1813, Vol. 50, no 4, 255-259 p.Article in journal (Refereed) PublishedText
Abstract [en]

Objective: The aim of this study was to create a model for predicting progression-free survival after radical prostatectomy for localized prostate cancer. Material and methods: The risk of biochemical recurrence (BCR) was modelled in a cohort of 3452 men aged 70 years or younger who were primarily treated with radical prostatectomy after being diagnosed between 2003 and 2006 with localized prostate cancer [clinical stage T1c-T2, Gleason score 5-10, N0/NX, M0/MX, prostate-specific antigen (PSA)<20 ng/ml]. The cohort was split into two: one cohort for model development (n = 3452) and one for validation (n = 1762). BCR was defined as two increasing PSA values of at least 0.2 ng/ml, initiation of secondary therapy, distant metastases or death from prostate cancer. Multivariable Cox proportional hazard regression was applied, predictive performance was assessed using the bootstrap resampling technique to calculate the c index, and calibration of the model was evaluated by comparing predicted and observed Kaplan-Meier 1 year BCR. Results: The overall 5 year progression-free survival was 83% after a median follow-up time of 6.8 years in the development cohort and 7.3 years in the validation cohort. The final model included T stage, PSA level, primary and secondary Gleason grade, and number of positive and negative biopsies. The c index for discrimination between high and low risk of recurrence was 0.68. The probability of progression-free survival ranged from 22% to 97% over the range of risk scores in the study population. Conclusions: This model is based on nationwide population-based data and can be used with a fair predictive accuracy to guide decisions on clinical follow-up after prostatectomy. An online calculator for convenient clinical use of the model is available at www.npcr.se/nomogram

Place, publisher, year, edition, pages
2016. Vol. 50, no 4, 255-259 p.
Keyword [en]
Biochemical recurrence, nomogram, predictive models, prostate cancer, radical prostatectomy
National Category
Surgery Urology and Nephrology
URN: urn:nbn:se:uu:diva-300104DOI: 10.1080/21681805.2016.1183226ISI: 000379024000003PubMedID: 27192553OAI: oai:DiVA.org:uu-300104DiVA: diva2:950808
Swedish Research Council, K2014-66X-20760-07-4 825-2012-5047Swedish Cancer Society, 14 0274 13 0428 2011 825 12 0475
Available from: 2016-08-02 Created: 2016-08-02 Last updated: 2016-08-02Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Stattin, Pär
By organisation
In the same journal
Scandinavian journal of urology
SurgeryUrology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 14 hits
ReferencesLink to record
Permanent link

Direct link